UCSF-UCB Tuberculosis Research Advancement Center (TRAC)

UCSF-UCB 结核病研究促进中心 (TRAC)

基本信息

  • 批准号:
    10674698
  • 负责人:
  • 金额:
    $ 96.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-02 至 2027-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The overall goal of the proposed UC San Francisco – UC Berkeley Tuberculosis Research Advancement Center (UCSF-UCB TRAC) is to accelerate the pace of discoveries that improve our understanding of tuberculosis (TB) and lead directly to new tools for diagnosis, prevention, and treatment of TB. Addressing the complex problems of the current heavy burden and persistence of the TB epidemic requires partnerships across disciplines; mobilization of technology for identification, intervention, and prevention; and mentoring of future scientists and clinicians. The UCSF-UCB TRAC is uniquely positioned to address these challenges for radically new treatments, better diagnostics and an effective vaccine. UCSF and UCB represent a major hub of NIH-funded TB research with many labs across the wide spectrum of disciplines, and the UCSF-UCB TRAC will fill a critical gap in a prominent clinical and basic science research environment. Our proposed UCSF-UCB TRAC will allow us to, (1) attract and support New Investigators (NI) in the TB field by providing pilot awards, training, longitudinal mentorship and other key services and resources; and (2) attract and enable non-TB investigators to enter the field by providing awards, key resources and opportunities for multidisciplinary collaboration that support new directions in TB research. Further, our Center tightly integrates 4 cores: 1) an Administrative Core to provide leadership, infrastructure, administrative and communication support, advice and oversight to coordinate all UCSF-UCB TRAC operations; 2) a Basic Science Core to lower traditional barriers experienced by investigators to facilitate innovative, multidisciplinary, fundamental TB research through a suite of cutting edge technologies accessible in BSL-3/ABSL-3 facilities; 3) a Clinical Science Core to augment existing UCSF and UCB resources to accelerate clinical research by engaging new investigators and reducing the barrier to conducting high-quality, innovating clinical research; and 4) a Developmental Core to attract and develop scientific leaders in TB research via a platform of services to support a continuum of ideas to independence in TB research, offering mentoring, professional development, proposal support, and research funding. The UCSF-UCB TRAC will add value to the robust research enterprises of UCSF and UC Berkeley by bridging traditional silos between fundamental and clinical TB and by providing a nucleating factor for coordinated TB research resources and collaboration at the two campuses and at affiliated international research sites.
项目总结 加州大学旧金山分校-加州大学伯克利分校结核病研究促进中心的总体目标 (加州大学旧金山分校-UCB TRAC)将加快发现的步伐,以提高我们对结核病(TB)的了解 并直接导致诊断、预防和治疗结核病的新工具。解决复杂的问题 目前结核病流行的沉重负担和持久性需要跨学科的伙伴关系; 调动用于识别、干预和预防的技术;以及指导未来的科学家和 临床医生。加州大学旧金山分校-UCB TRAC具有独特的地位,可以应对这些全新的挑战 治疗、更好的诊断和有效的疫苗。加州大学旧金山分校和联合银行是NIH资助的主要枢纽 与广泛学科的许多实验室进行的结核病研究,以及加州大学旧金山分校-UCB TRAC将填补关键 突出的临床和基础科学研究环境中的差距。我们提议的加州大学旧金山分校-UCB TRAC将允许 美国将,(1)通过提供试点奖励、培训、纵向培训等方式吸引和支持结核病领域的新研究人员 指导和其他主要服务和资源;以及(2)吸引和使非结核病调查人员能够进入 通过提供奖项、关键资源和多学科协作机会来支持新的 结核病研究的方向。此外,我们的中心紧密集成了4个核心:1)管理核心,以提供 领导、基础设施、行政和沟通支持、咨询和监督,以协调所有 加州大学旧金山分校-UCB TRAC业务;2)降低调查人员面临的传统障碍的基础科学核心 通过一套尖端技术促进创新的、多学科的基础结核病研究 可在BSL-3/ABSL-3设施中使用;3)临床科学核心,以增强现有的加州大学旧金山分校和UCB资源 通过聘用新的研究人员和降低进行高质量研究的障碍来加快临床研究, 创新临床研究;以及4)开发核心,以吸引和培养结核病研究领域的科学领军人物 通过一个服务平台来支持结核病研究的独立性、提供指导、 专业发展、提案支持和研究资金。加州大学旧金山分校-UCB TRAC将为 加州大学旧金山分校和加州大学伯克利分校通过弥合基础和 通过为协调的结核病研究资源和合作提供核心因素 两个校区和附属的国际研究地点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEFFERY S COX其他文献

JEFFERY S COX的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEFFERY S COX', 18)}}的其他基金

UCSF-UCB Tuberculosis Research Advancement Center (TRAC)
UCSF-UCB 结核病研究促进中心 (TRAC)
  • 批准号:
    10431539
  • 财政年份:
    2022
  • 资助金额:
    $ 96.85万
  • 项目类别:
M. tuberculosis strain-dependent interactions with host cells
结核分枝杆菌与宿主细胞的菌株依赖性相互作用
  • 批准号:
    10459539
  • 财政年份:
    2021
  • 资助金额:
    $ 96.85万
  • 项目类别:
M. tuberculosis strain-dependent interactions with host cells
结核分枝杆菌与宿主细胞的菌株依赖性相互作用
  • 批准号:
    10653910
  • 财政年份:
    2021
  • 资助金额:
    $ 96.85万
  • 项目类别:
Host Pathogen Variation & TB Pathogenesis
宿主病原体变异
  • 批准号:
    10459534
  • 财政年份:
    2021
  • 资助金额:
    $ 96.85万
  • 项目类别:
Host Pathogen Variation & TB Pathogenesis
宿主病原体变异
  • 批准号:
    10271168
  • 财政年份:
    2021
  • 资助金额:
    $ 96.85万
  • 项目类别:
M. tuberculosis strain-dependent interactions with host cells
结核分枝杆菌与宿主细胞的菌株依赖性相互作用
  • 批准号:
    10271172
  • 财政年份:
    2021
  • 资助金额:
    $ 96.85万
  • 项目类别:
Host Pathogen Variation & TB Pathogenesis
宿主病原体变异
  • 批准号:
    10653900
  • 财政年份:
    2021
  • 资助金额:
    $ 96.85万
  • 项目类别:
RESEARCH PROJECT 2
研究项目2
  • 批准号:
    10224018
  • 财政年份:
    2018
  • 资助金额:
    $ 96.85万
  • 项目类别:
PROJECT 1: Identification of host and bacterial pathways that control tuberculosis pathogenesis in humans
项目 1:鉴定控制人类结核病发病机制的宿主和细菌途径
  • 批准号:
    10550001
  • 财政年份:
    2018
  • 资助金额:
    $ 96.85万
  • 项目类别:
Research Training at the Confluence of Infectious and Non-Communicable Diseases in India
印度传染病和非传染性疾病交汇处的研究培训
  • 批准号:
    10361555
  • 财政年份:
    2017
  • 资助金额:
    $ 96.85万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 96.85万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 96.85万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.85万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.85万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 96.85万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.85万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 96.85万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 96.85万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 96.85万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.85万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了